trump-xi-banner-under-100kb

Trump–Xi summit: Stability, not a breakthrough

Macro 6 minutes to read

Key points:

  • Stability, not a breakthrough: Trump and Xi extended the trade truce to 10 January 2027, lowering the risk of immediate escalation.
  • The hard issues remain open: There were no detailed new tariff cuts or firm commitments on rare earths and AI chips. Taiwan and Iran were discussed without a resolution.
  • Markets need proof, not just warm optics: The outcome may support sentiment briefly, but a sustained re-rating of Chinese equities would need concrete policy changes and evidence they are being implemented.


US President Donald Trump and Chinese President Xi Jinping met in Washington on 24 September, just over four months after their talks in Beijing. They extended the US–China trade truce by two months, to 10 January 2027, and signalled that negotiations would continue. But the meeting produced no detailed list of tariff cuts or firm new commitments on rare-earth supplies and advanced chips.

What happened on the five key issues?

1. Tariffs: the pause survived, but the detail did not arrive. Before the meeting, investors were watching for tariff reductions on a defined list of goods. Instead, the main result was a short extension of the existing truce. That is better than a return to escalation, but a two-month window leaves the same question hanging over importers, exporters and their investment plans: what happens after 10 January?

2. Agriculture: existing soybean purchases are on track. US Treasury Secretary Scott Bessent said China was meeting its commitment to buy 25 million tonnes of US soybeans, while purchases of other agricultural products were lagging. The summit did not establish a clear additional purchase commitment. For soybean markets, the next signal will come from actual buying and any reduction in barriers that encourages commercial buyers to return.

3. Rare earths: the supply concern remains. These materials and magnets are important to industries from aerospace to electronics. US officials said Chinese deliveries were falling short of earlier commitments, and no detailed new supply guarantee emerged from the meeting. Investors should watch export licences and shipments. Smoother flows would help manufacturers reliant on Chinese inputs, but could also temper enthusiasm for alternative suppliers whose shares reflect a scarcity premium.

4. AI chips: dialogue has not changed the export rules. Trump and Xi discussed AI cooperation and safety, but announced no easing of restrictions on advanced chips or semiconductor equipment. That leaves a distinction for investors: diplomatic dialogue may reduce the chance of misunderstandings, while specific export licences or rule changes would have a more direct effect on chipmakers’ sales.

5. Taiwan and Iran: both were discussed, neither was resolved. Xi urged Washington to handle Taiwan with caution and pressed for a stronger US stance against Taiwanese independence. There was no reported change in US policy. On Iran, Xi called for a return to negotiations, but no new joint agreement emerged. Taiwan therefore remains a risk for the advanced chip supply chain, while developments around Iran will matter more for oil and inflation than the summit’s diplomatic tone.

Why was the summit short on detail?

The timing may have helped produce a pause. With US midterm elections approaching, a new trade escalation would be politically costly, particularly if it added to pressure on prices or hurt farmers. China also gains from keeping trade flows stable. That gave both leaders a reason to extend the truce, even without settling their larger differences.

But the short extension is also a measure of the distance between them. Soybean purchases and continued talks are easier to deliver than lasting concessions on tariffs, rare earths or advanced chips. The two sides agreed to keep negotiating; they have yet to show that they can narrow the hardest gaps.

What should investors expect now?

The outcome is better than an escalation but weaker than markets had hoped for. Chinese and Hong Kong stocks had risen earlier in the week on hopes of a truce, then slipped on Thursday as expectations of a broader breakthrough cooled. A short pause can support sentiment, but it offers a thin basis for a sustained re-rating of Chinese equities.

The upside risk to this cautious view is that the extension becomes a bridge to specific tariff cuts and more dependable critical-mineral supplies. The downside is that slow implementation turns the January deadline into another confrontation. For now, the summit has reduced near-term tail risk, while leaving the longer-term geopolitical risk premium largely intact.

Disclaimer

The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.